
|Articles|November 1, 2003
REGIMEN FOR SKIN INFECTIONS
New data suggest InterMune Inc.'s intravenous oritavancin is as effective as a regimen of vancomycin plus cephalexin in treating patients with complicated skin and skin-structure infections (CSSSI).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements
2
Psychodermatology’s Role in Strengthening Therapeutic Connections
3
Day 4 Recap: Elevate-Derm Fall Conference
4
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
5



















